MAPT and amyloidosis: In our short-term experiment, although quetiapine has shown to have benefits in amyloid animal models in terms of reduced inflammation and improvement in memory at the dose used in this study [69,70], we did not identify significant changes in locomotor activity following short exposure in tau mice.